Go Pro

10,364 Shares in HCA Healthcare, Inc. $HCA Acquired by Commerce Bank

HCA Healthcare logo with Healthcare background
Image from MarketBeat Media, LLC.

Commerce Bank purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 10,364 shares of the company's stock, valued at approximately $4,041,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC lifted its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock valued at $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after acquiring an additional 33 shares in the last quarter. Jump Financial LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $2,073,000. Finally, Sei Investments Co. increased its holdings in HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company's stock valued at $52,328,000 after purchasing an additional 49,214 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.0%

Shares of NYSE:HCA opened at $429.19 on Tuesday. The firm has a market cap of $92.92 billion, a PE ratio of 14.37, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The company has a fifty day simple moving average of $397.94 and a 200 day simple moving average of $443.28.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company's revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.84 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is 10.45%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Cantor Fitzgerald decreased their target price on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating for the company in a research report on Tuesday, July 7th. KeyCorp decreased their price target on HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a report on Monday, July 27th. Weiss Ratings lowered shares of HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 9th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 14th. Finally, UBS Group cut their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and an average target price of $462.64.

Read Our Latest Research Report on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines